| MRNA | Moderna Inc | 1.88% |
| RARE | Ultragenyx Pharmaceutical Inc | 1.84% |
| PGEN | Precigen Inc | 1.72% |
| AGIO | Agios Pharmaceuticals Inc | 1.69% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.68% |
| LGND | Ligand Pharmaceuticals Inc | 1.66% |
| IBRX | ImmunityBio Inc Ordinary Shares | 1.65% |
| KNSA | Kiniksa Pharmaceuticals International PLC Class A | 1.65% |
| ASND | Ascendis Pharma AS | 1.64% |
| CYTK | Cytokinetics Inc | 1.63% |
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
Virtus Biotech ETF · Issued by Virtus
No recent news for BBP. The ingest cron pulls every 15 minutes during market hours.